Literature DB >> 32101454

Implications of the evidence for breast conservation therapy in BRCA-gene mutation carriers.

Mona P Tan1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32101454      PMCID： PMC7362920          DOI： 10.1259/bjr.20200038

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  10 in total

1.  Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Chyke A Doubeni; John W Epling; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

Review 2.  Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view.

Authors:  Alexis Vallard; Nicolas Magné; Jean-Baptiste Guy; Sophie Espenel; Chloé Rancoule; Peng Diao; Eric Deutsch; Sofia Rivera; Cyrus Chargari
Journal:  Br J Radiol       Date:  2019-02-27       Impact factor: 3.039

3.  Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.

Authors:  Gianluca Franceschini; Alba Di Leone; Daniela Terribile; Martin Alessandro Sanchez; Riccardo Masetti
Journal:  Ann Ital Chir       Date:  2019       Impact factor: 0.766

4.  Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.

Authors:  S Hofvind; Å Holen; T Aas; M Roman; S Sebuødegård; L A Akslen
Journal:  Eur J Surg Oncol       Date:  2015-07-17       Impact factor: 4.424

5.  Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.

Authors:  Shailesh Agarwal; Lisa Pappas; Leigh Neumayer; Kristine Kokeny; Jayant Agarwal
Journal:  JAMA Surg       Date:  2014-03       Impact factor: 14.766

Review 6.  The sick lobe hypothesis, field cancerisation and the new era of precision breast surgery.

Authors:  Mona P Tan; Tibor Tot
Journal:  Gland Surg       Date:  2018-12

7.  Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.

Authors:  Allison W Kurian; Daphne Y Lichtensztajn; Theresa H M Keegan; David O Nelson; Christina A Clarke; Scarlett L Gomez
Journal:  JAMA       Date:  2014-09-03       Impact factor: 157.335

8.  Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.

Authors:  Eric R Manahan; Henry M Kuerer; Molly Sebastian; Kevin S Hughes; Judy C Boughey; David M Euhus; Susan K Boolbol; Walton A Taylor
Journal:  Ann Surg Oncol       Date:  2019-07-24       Impact factor: 5.344

9.  Survival implications associated with variation in mastectomy rates for early-staged breast cancer.

Authors:  John M Brooks; Elizabeth A Chrischilles; Mary Beth Landrum; Kara B Wright; Gang Fang; Eric P Winer; Nancy L Keating
Journal:  Int J Surg Oncol       Date:  2012-08-08

10.  Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017.

Authors:  Na Li; Yujiao Deng; Linghui Zhou; Tian Tian; Si Yang; Ying Wu; Yi Zheng; Zhen Zhai; Qian Hao; Dingli Song; Dai Zhang; Huafeng Kang; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2019-12-21       Impact factor: 17.388
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.